ARCHIVES

Study Finds High-Risk Women Reluctant To Take Tamoxifen

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

House Committee Adds $73 Million To President’s NCI Budget, Only $13 Million Under Senate Figure

August 3, 1984

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021